ZG-801 Phase II Trial - Exploratory Study of Efficacy and Safety on Patients With Hyperkalemia, and Long Term Safety Study
Latest Information Update: 15 Dec 2021
At a glance
- Drugs Patiromer (Primary)
- Indications Hyperkalaemia
- Focus Therapeutic Use
- Sponsors Zeria
Most Recent Events
- 23 Mar 2021 Status changed from active, no longer recruiting to completed.
- 03 Oct 2019 Status changed from recruiting to active, no longer recruiting.
- 01 Jul 2019 Status changed from not yet recruiting to recruiting.